Bencich John
- SEC CIK
- 0001477056
No open-market purchases or sales filed in the past year.
Current role at each company
- AEON AEON Biopharma, Inc.CHIEF FINANCIAL OFFICERas of Apr 3, 2026
- ACHV Achieve Life Sciences, Inc.CEOas of Aug 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bencich John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACHV Achieve Life Sciences, Inc.
CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Bencich JohnCEO | PPurchase | +10.0K | $4.59 | +$45.9K | +15.0%76.7K after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Bencich JohnCEO | PPurchase | +10.0K | $0.00 | $0 | –10.0K after | Derivative |
| Jun 1, 2023 (view filing) | May 30 | 2 days | Bencich JohnCEO | PPurchase | +5.00K | $5.50 | +$27.5K | +8.1%66.7K after | |
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Bencich JohnCEO | PPurchase | +22.0K | – | – | +147.5%36.9K after | |
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Bencich JohnCEO | PPurchase | +11.0K | – | – | –11.0K after | Derivative |